Dr. Boucher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 Washington St
Boston, MA 02111Phone+1 617-636-5000Fax+1 617-636-8525
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1997 - 2000
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1997
- McGovern Medical School at UTHealthClass of 1993
Certifications & Licensure
- MA State Medical License 1996 - 2026
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2010-2013
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- The pre-transplant evaluation: Considerations for trainees and early career transplant infectious diseases clinician.Rebecca N Kumar, Chelsea A Gorsline, Theodore Rader, Helen W Boucher, Maricar Malinis
Transplant Infectious Disease. 2024-08-01 - Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for An...Tori Kinamon, Ursula Waack, Mark Needles, Daniel Rubin, Deborah Collyar
Clinical Infectious Diseases. 2024-07-19 - New Antibiotics for Resistant Infections: What Happens After Approval?Jessica Howard-Anderson, Helen W Boucher
Annals of Internal Medicine. 2024-05-01
Journal Articles
- U.S. Efforts to Curb Antibiotic Resistance — Are We Saving Lives?Sameer S Kadri, Helen W Boucher, The New England Journal of Medicine
- Emergency Use Authorization of RemdesivirMichael G Ison, Cameron Wolfe, Helen W Boucher, JAMA
- Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcu...Helen W Boucher, Sara E Cosgrove, G Ralph Corey, Thomas L Holland, Vance G Fowler, Clinical Infectious Diseases
- Join now to see all
Authored Content
- U.S. Efforts to Curb Antibiotic Resistance — Are We Saving Lives?August 2020
- Emergency Use Authorization of RemdesivirMay 2020
Press Mentions
- New Antibiotics Aren’t Being Fully Used, Study FindsApril 23rd, 2024
- Learn About Some of Tufts University School of Medicine's Amazing Trailblazing Alumni and FacultyMarch 7th, 2023
- Dr. Kathleen Finn Appointed Louisa C. Endicott Professor of MedicineFebruary 27th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: